Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AstraZeneca PLC ADS (NY: AZN)
52.35 USD  +0.64 (+1.24%)
Official Closing Price  /  Updated: 4:15 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about AstraZeneca PLC ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
All Penny Stocks.com News: Aradigm Corp Shares Rise on Exclusive License Deal with Grifols
Today 10:05 EDT
Mississauga, ON -- (SBWIRE) -- 05/22/2013 -- AllPennyStocks.com Media, Inc. (AllPennyStocks.com/) announces its latest article titled “Aradigm Corp Shares Rise on Exclusive License Deal with Grifols.” Read More
from SBWire - Latest Press Releases
Bulls taking Control of AstraZeneca?
Today 1:09 EDT
New York, May 22nd (TradersHuddle.com) - Shares of AstraZeneca PLC ( NYSE:AZN ) ended the trading session higher by $0.22 or 0.43% from its previous close. AstraZeneca's price action formed what is... Read More
from TradersHuddle.com
Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
May 21, 2013
from Business Wire News Releases
AstraZeneca closes in on site for new home in Cambridge
May 20, 2013
* New research centre and corporate HQ to cost some $500 mln Read More
category companyNews
from Reuters: Company News
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
May 18, 2013
Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they... Read More
category GHDX , Benzinga , Murphy Oil , and 35 more.
from Latest Articles from Benzinga.com
AstraZeneca - Shares Seeking Direction
May 17, 2013
New York, May 17th (TradersHuddle.com) - Shares of AstraZeneca PLC ( NYSE:AZN ) closed the trading day higher by $0.08 or 0.15% from its previous close. AstraZeneca's price action formed what is... Read More
from TradersHuddle.com
Cheerleaders: Look Beyond Pharma For Jobs
May 16, 2013
category AZN , ABBV , TSPT , and 5 more.
from YCharts
AstraZeneca accelerates cancer drug testing
May 16, 2013
* Final-stage studies on olaparib, selumetinib start in H2 Read More
category companyNews
from Reuters: Company News
Benzinga's M&A Chatter for Wednesday May 15, 2013
May 15, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday May 15, 2013: Hearing Chatter Cisco May Bid $75/Share to Acquire Red Hat The Rumor:Shares of Red Hat (NYSE:... Read More
category S , ORCL , Benzinga , and 14 more.
from Latest Articles from Benzinga.com
UPDATE 1-Dish lines up banks to finance Sprint bid -sources
May 15, 2013
NEW YORK, May 15 (Reuters) - Dish Network Corp has lined up four banks to finance its $25.5 billion bid for Sprint Nextel Corp, escalating the bidding war against Japanese telecom company SoftBank... Read More
category companyNews
from Reuters: Company News
Should I Buy Pfizer? 3 Pros, 3 Cons
May 15, 2013
 Read More
category NYSE:MRK , Stocks to Buy , NYSE:PFE , and 3 more.
from InvestorPlace - Latest Headlines
A taste for defensives sours prospects for European stocks
May 14, 2013
LONDON, May 14 (Reuters) - Defensive stocks such as healthcare companies, which often bring up the rear when markets rise, have led the gainers in 2013 as European bourses hit their highest in years,... Read More
category companyNews
from Reuters: Company News
Benzinga's M&A Chatter for Monday May 13, 2013
May 13, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday May 13, 2013: AsiaInfo-Linkage to be Acquired by Group Led by CITIC Capital Partners for $12.00/Share in Cash... Read More
category AZN , Rumors , Benzinga , and 12 more.
from Latest Articles from Benzinga.com
Optimer Pharmaceuticals (OPTR) Jumps as AstraZeneca (AZN), Cubist (CBST) Submit First Round Bids
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8331970 for the full story. Read More
from StreetInsider.com News Articles
Assessing Your Asthma is Key to Taking Control
May 13, 2013
from PR Newswire
“Marketing Without Innovation”: a Merck Story
May 10, 2013
category AZN , MRK , GSK , and 3 more.
from YCharts
(AZN) AstraZeneca Inks Biomarker Discovery Deal
May 09, 2013
AstraZeneca (AZN) recently announced that it has entered into an agreement with UK-based company,... Visit StockBlogHub to view complete post. Read More
category XOMA , AZN , Athersys Inc , and 5 more.
from Stock Blog Hub
Six Superstars for Your Biotech Portfolio: John McCamant
May 09, 2013
Six Superstars for Your Biotech Portfolio: John McCamant Source: Tracy Salcedo-Chourr? of The Life Sciences Report (5/9/13) http://www.thelifesciencesreport.com/pub/na/15256 We are in the “golden age,”... Read More
category AZN , JNJ , ALKS , and 8 more.
from Bio-Wire.Com
Pharma’s Failure: Drug Spending Finally Declines
May 09, 2013
category AZN , MRK , GSK , and 3 more.
from YCharts
U.S. spending on medicines fell for first time in 2012
May 08, 2013
May 9 (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years,... Read More
category companyNews
from Reuters: Company News
The New Diet Pill Players: Arena and Vivus
May 08, 2013
category AZN , ARNA , ABT , and 1 more.
from YCharts
Small Companies Are Leading Innovation For New Drugs To Treat Depression
May 07, 2013
Back in 2011, two British professors, Guy Goodwin (Oxford University) and David Nutt (Imperial College London), co-authored a report entitled “Funding crisis threatens development of new treatments for... Read More
category NYSE:NVS , NYSE:MRK , NYSE:PFE , and 2 more.
from Forbes Real Time
Former AstraZeneca N.A. CEO to Serve as Senior Advisor to VIVUS (VVUS)
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8310523 for the full story. Read More
from StreetInsider.com News Articles
Biotechs and Nanomedicine Investing
May 06, 2013
Through molecular technology, drug developers are now able to target specific diseased cells and tissue. And several companies are at the forefront... Read More
from Wealth Daily
Even Pharma's Good Deeds Are Criticized
May 06, 2013
The pharmaceutical industry is far from perfect and previous posts have discussed some of these problems. However, this industry plays a major role in the discovery and development of new medicines.... Read More
category NYSE:NVS , NYSE:MRK , NYSE:GSK , and 1 more.
from Forbes Real Time
Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Perio
May 06, 2013
from Business Wire News Releases
Merck's Cholesterol Pill Win Is Already Drawing Fire
May 03, 2013
The Food and Drug Administration just approved Liptruzet, a new cholesterol-lowering pill that combines the generically available ingredient available in Pfizer's Lipitor with Merck's Zetia. Merck has... Read More
category NYSE:MRK , NYSE:PFE , NYSE:AZN
from Forbes Real Time
PPH, SNY, GSK, AZN: ETF Outflow Alert
May 03, 2013
Symbols mentioned in this story: PPH, SNY, GSK, AZN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Big drugmakers think small with nanomedicine deals
May 03, 2013
* Early-stage research but scientists see momentum building Read More
category companyNews
from Reuters: Company News
GSK, AZN, KERX, and RPTP Early Briefing and Review
May 02, 2013
from ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

AstraZeneca PLC ADS (AZN) Stock News

Welcome to the AstraZeneca PLC ADS stock news page which features stock news from multiple mainstream financial sources. A few of the stock news sources you can find articles from are Investopedia Advistor Commentary, Business Wire News Releases, Energy and Capital, StreetInsider.com News Articles, Fool.com, iStockAnalysst.com and featured blog articles from Stocknod.com. We are your number one stock news source for AstraZeneca PLC ADS (GM).

More Stock News for AstraZeneca PLC ADS

Stocknod is a premier financial information website that provides business news, analysis and stock market data to more than 5 million visitors every year. Stocknod offers personal finance news and advice, tools for investors and access to industry research. With breaking stock market news and real-time stock prices, Stocknod is your #1 source for top rated market news. Join Stocknod for stock trading signalsand stock trading softwarefor superior stock market timing.